Espín-Paredes E, Guevara-López U, Arias-Rosa JC, Pérez-Carranco ML

Idioma: Español
Referencias bibliográficas: 25
Paginas: 69-73
Archivo PDF: 173.22 Kb.

RESUMEN

Se ha considerado a la diabetes mellitus (DM) un problema de salud pública, asociado a daño de diversos órganos y dolor secundario a polineuropatía. Objetivo: Identificar los factores de riesgo asociados al desarrollo de neuropatía diabética dolorosa (NDD). Método: En forma retrospectiva, descriptiva y comparativa, se estudiaron a 87 pacientes, divididos en 2 grupos: a) enfermos con neuropatía diabética dolorosa (NDD) y b) pacientes con neuropatía diabética no dolorosa NDND. Resultados: Se encontró una prevalencia de NDD mayor que de NDND; diferencias estadísticamente significativas entre grupos respecto a la glicemia, hemoglobina glicosilada y años de evolución de la diabetes, mayor frecuencia de NDD en el sexo femenino, una aparición más temprana a lo reportado y comorbilidades del tipo de la hipertensión arterial, dislipidemias y trastornos del sueño.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Bredley SG, Giannas A, et al. Painful diabetic polyneuropathy: epidemiology, pain description and quality of life. Diabetes Research and Clinical Practice 2000;47:123-128.

2. Betancourt JA, Covarrubias GA, Guevara LU. Mecanismos generadores y consideraciones terapéuticas futuras de la polineuropatía diabética dolorosa. Rev Mex Anest 2008;31:28-36.

3. Miser WF. The management of type 2 diabetes mellitus FOCUS on Quality. Prim Care Clin Office Prac 2007;34:1-38.

4. American Diabetes Association. Standards of medical care in diabetes 2008. Diabetes Care 2008;31:s12-s24.

5. Huizinga MM, Peltier A, et al. Painful diabetic neuropathy: A management centered review. Clinical Diabetes 2007;25:2-10.

6. Tunks ER, Crook J, et al. Epidemiology of chronic pain with psychological comorbidity: Prevalence, risk, course and prognosis. Can J Psychiatric 2008;53:24-34.

7. Gore M, Brendenburg NA, et al. Sleep impairment in patients with painful diabetic peripheral neuropathy. Clin J Pain 2006;22:681-685.

8. Gonzalez-Clemente JM, Palma S, et al. Is diabetic mellitus coronary heart disease equivalent? Results of a meta-analysis of prospective studies. Rev Esp Cardiol 2007;60:1167-1670.

9. Steter C, Alleman S, et al. Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials. American Heart Journal .2006;152:27-38.

10. Crawford1 F, Inkster M, et al. Predicting foot ulcers in patients with diabetes: a systematic review and meta-analysis. Q J Med 2007;100:65-86.

11. American Diabets Association. Standards of Medical Care in Diabetes-2008. Diabetes Care 2008;31:12-24.

12. Selvin E, Marinopoulos S, et al. Meta-analysis: Glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 2004:141:421-431.

13. Huizinga MM, Amanda Peltier A. Painful diabetic neuropathy: A management-centered review. Clinical Diabetes 2007;25:6-15.

14. Boulton AJM. Diabetic neuropathy: classification, measurement and treatment. Current Opinion in Endocrinology & Diabetes 2007;14:141-145.

15. Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ 2006;332:73-78.

16. Stettler C, Allemann S, et al. Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials. Am Heart J 2006;152:27-38.

17. Mayer-Davis EJ. Type 2 diabetes in Youth: Epidemiology and current research toward prevention and treatment. J Am Diet Assoc 2008;108:S45-S51

18. Sorensen L, Siddal PJ, et al. Differences in metabolites in pain-processing brain regions in patients with diabetes and painful neuropathy. Diabetes Care 2008;31:980- 981.

19. Polityshka LJ, et al. Quality of life its relationship to the degree of illness acceptance in patients with diabetes and peripheral diabetic neuropathy. Advances in Medical Sciences 2007;52:144-147.

20. Maser RE, Braxton DM, et al. The Association Between cardiovascular autonomic neuropathy and mortality in individuals with diabetes. Diabetes Care 2003;26:1895-1901.

21. Duby JJ, Campbell RK, et al. Diabetic neuropathy: An intensive review. Am J Health Syst Pharm 2004;61:114-122.

22. Roy-Byrne PP, Davidson WD, et al. Anxiety disorders and comorbid medical illness. General Hospital Psychiatry 30 2008:208-225.

23. Miser WF. The management of type 2 diabetes mellitus FOCUS on quality. Prim Care Clin Office Pract 2007:1-38.

24. Va´rkonyi1 T, Kempler P. Diabetic neuropathy: new strategies for treatment. Diabetes Obesity and Metabolism 2008;10:99-108 .

25. Sadosky A, McDermott AM, Brandenburg NA. A Review of the epidemiology of painful diabetic peripheral neuropathy, postherpetic neuralgia, and less commonly studied neuropathic pain conditions. Pain Practice 2008;8:45–56.